Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location:Home > Pharma China Web Edition > Feature Articles    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Feature Articles
 
Why Most Small Players May Not Survive China's Pharmaceutical Ind... 1/30/2018
Compliance in China: Key Considerations 1/30/2018
Made in China: New and Potentially Lifesaving Drugs 1/19/2018
Update on US Investigation of China's IP Practices 1/19/2018
Fosun-Backed Shanghai Henlius Biotech Eyes IPOs on Both Mainland ... 1/19/2018
Hua Medicine Mulls Hong Kong IPO as Diabetes Drug Enters Crucial ... 1/18/2018
New Opportunities in Emerging Markets 1/18/2018
China's Medical Representative Registration System: Action Items ... 1/17/2018
China's Recent Development on Granting Biological Sequence Claims... 1/11/2018
CFDA Seeks Comments on the Amendments of Administrative Measures ... 1/11/2018
Amendments Of Anti-Unfair Competition Law 1/4/2018
China FDA Solicits Comments on Conditional Approvals for New Drug... 1/2/2018
China Advances Drug Regulatory Reform amid Slowing Growth 12/29/2017
How to Protect Trade Secrets in China When Employees Leave 12/28/2017
New Circular Further Enhancing the Development of the Market Auth... 12/28/2017
Why Is China Seeing A Huge Increase in Breast Cancer Rates 12/26/2017
Hospitals' Cost-Cutting Efforts Have Netizens Sick With Worry 12/26/2017
GMP Certificate Cancellation in China: Concern Or Relief? 12/21/2017
Examination Practice of Antibody-Related Patent Applications In C... 12/20/2017
Patent Issues for Life Science Companies in China 12/19/2017
Legal Debriefs: The Revised Administrative Measures for Drug Regi... 12/19/2017
Highlights On China's Comprehensive Regulatory Reform of Drugs an... 12/19/2017
Hong Kong Helps Speed Up Development of New Treatments As Number ... 12/19/2017
Biopharmaceutical Manufacturing Growing Rapidly in China 12/4/2017
US Healthcare Could Be the Booster Shot That "Healthy China" Need... 12/4/2017
MNCs Play Defensive despite China's Renewed Access and Trade Pled... 11/30/2017
Expect More US Corruption Probes Involving Firms with Links to Ch... 11/23/2017
Investors Place Bet on Chinese Drugmakers 11/23/2017
China's FDA Reform Will Encourage Life Science Innovation 11/23/2017
Guangzhou Pharma Reveals Grand Plan 11/22/2017
Page:3/5  Total number of articles:145  [1][2][3][4][5]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links